Cti Biopharma Corp

STATE STREET CORP

Report date

3/31/2023

Quarter

2023 Q1

Filed

5/15/2023

Shares

12,437,278

Value ($000)

52,237

Weight

0.0%

2019 Q4 - 2023 Q1 (14 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q1	5/15/2023	52,237	0.0%	12,437,278	3/31/2023
2022 Q4	5/15/2023	96,178	0.0%	16,002,989	12/31/2022
2022 Q3	11/15/2022	79,982	0.0%	13,742,554	9/30/2022
2022 Q2	8/15/2022	58,802	0.0%	9,849,528	6/30/2022
2022 Q1	5/16/2022	1,267	0.0%	271,335	3/31/2022
2021 Q4	2/14/2022	529	0.0%	213,314	12/31/2021
2021 Q3	11/15/2021	629	0.0%	213,314	9/30/2021
2021 Q2	8/16/2021	414	0.0%	165,414	6/30/2021
2021 Q1	7/9/2021	62	0.0%	21,152	3/31/2021
2020 Q4	2/16/2021	58	0.0%	18,052	12/31/2020
2020 Q3	11/10/2020	39	0.0%	18,052	9/30/2020
2020 Q2	8/14/2020	21	0.0%	18,052	6/30/2020
2020 Q1	6/19/2020	17	0.0%	18,052	3/31/2020
2019 Q4	2/6/2020	29	0.0%	18,052	12/31/2019